News
Fideres Writes To The European Commission To Flag The Anticompetitive Implications Of IBAN Discrimination
Fideres flags the anticompetitive implications of IBAN discrimination with the European Commission.
The Philadelphia Inquirer recently covered Fideres’s recent research on price increases of generic drugs as part of a full examination of the pharmaceutical industry.
Alberto Thomas, founding partner at Fideres, is quoted as describing the price increases as occurring “without any meaningful increases in the costs of materials or production costs or breakdown of factories or other disruption to the supply chain. That’s what makes this very suspicious.”
The full article by the Philadelphia Inquirer can be found here.
Fideres flags the anticompetitive implications of IBAN discrimination with the European Commission.
The Italian law firm Scoccini & Associati and the Spanish law firm CCS Abogados, supported by the litigation fund ALI – Antritrust Litigation...
Fideres’s Analyst, Marco Ragusa, was awarded second place in the fourth edition of the Luigi Prosperetti Graduation Award.
London: +44 20 3397 5160
New York: +1 646 992 8510
Rome: +39 06 8587 0405
Frankfurt: +49 61 7491 63000
Johannesburg: +27 11 568 9611
Madrid: +34 919 494 330